Literature DB >> 21088134

CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells.

Jennifer D Bassett1, Teng Chih Yang, Dannie Bernard, James B Millar, Stephanie L Swift, A J Robert McGray, Heather VanSeggelen, Jeanette E Boudreau, Jonathan D Finn, Robin Parsons, Carole Evelegh, Daniela Damjanovic, Natalie Grinshtein, Maziar Divangahi, Liang Zhang, Zhou Xing, Yonghong Wan, Jonathan L Bramson.   

Abstract

We have recently reported that CD8(+) T-cell memory maintenance after immunization with recombinant human adenovirus type 5 (rHuAd5) is dependent upon persistent transgene expression beyond the peak of the response. In this report, we have further investigated the location and nature of the cell populations responsible for this sustained response. The draining lymph nodes were found to be important for primary expansion but not for memory maintenance, suggesting that antigen presentation through a nonlymphoid source was required. Using bone marrow chimeric mice, we determined that antigen presentation by nonhematopoietic antigen-presenting cells (APCs) was sufficient for maintenance of CD8(+) T-cell numbers. However, antigen presentation by this mechanism alone yielded a memory population that displayed alterations in phenotype, cytokine production and protective capacity, indicating that antigen presentation through both hematopoietic and nonhematopoietic APCs ultimately defines the memory CD8(+) T-cell response produced by rHuAd5. These results shed new light on the immunobiology of rHuAd5 vectors and provide evidence for a mechanism of CD8(+) T-cell expansion and memory maintenance that relies upon both hematopoietic and nonhematopoietic APCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088134     DOI: 10.1182/blood-2010-03-272336

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  Murine superficial lymph node surgery.

Authors:  Mélissa Mathieu; Nathalie Labrecque
Journal:  J Vis Exp       Date:  2012-05-21       Impact factor: 1.355

2.  Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling.

Authors:  Kylie M Quinn; Daniel E Zak; Andreia Costa; Ayako Yamamoto; Kathrin Kastenmuller; Brenna J Hill; Geoffrey M Lynn; Patricia A Darrah; Ross W B Lindsay; Lingshu Wang; Cheng Cheng; Alfredo Nicosia; Antonella Folgori; Stefano Colloca; Riccardo Cortese; Emma Gostick; David A Price; Jason G D Gall; Mario Roederer; Alan Aderem; Robert A Seder
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

3.  miRNA-mediated silencing in hepatocytes can increase adaptive immune responses to adenovirus vector-delivered transgenic antigens.

Authors:  Matthias W Kron; Sigrid Espenlaub; Tatjana Engler; Reinhold Schirmbeck; Stefan Kochanek; Florian Kreppel
Journal:  Mol Ther       Date:  2011-05-10       Impact factor: 11.454

4.  Continuous CD8⁺ T-cell priming by dendritic cell cross-presentation of persistent antigen following adeno-associated virus-mediated gene delivery.

Authors:  Dan Xu; Christopher M Walker
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines.

Authors:  Jennifer D Bassett; Stephanie L Swift; Heather VanSeggelen; Joanne A Hammill; A J Robert McGray; Carole Evelegh; Yonghong Wan; Jonathan L Bramson
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

6.  Nicotine up-regulated 4-1BBL expression by activating Mek-PI3K pathway augments the efficacy of bone marrow-derived dendritic cell vaccination.

Authors:  Hao Jie Jin; Hua Xiu Sui; Yi Nan Wang; Feng Guang Gao
Journal:  J Clin Immunol       Date:  2012-08-17       Impact factor: 8.317

7.  Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation.

Authors:  Maria Abildgaard Steffensen; Peter Johannes Holst; Sanne Skovvang Steengaard; Benjamin Anderschou Holbech Jensen; Christina Bartholdy; Anette Stryhn; Jan Pravsgaard Christensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

8.  Modification of Antigen Impacts on Memory Quality after Adenovirus Vaccination.

Authors:  Julia M Colston; Beatrice Bolinger; Matthew G Cottingham; Sarah Gilbert; Paul Klenerman
Journal:  J Immunol       Date:  2016-03-04       Impact factor: 5.422

9.  A new model for CD8+ T cell memory inflation based upon a recombinant adenoviral vector.

Authors:  Beatrice Bolinger; Stuart Sims; Geraldine O'Hara; Catherine de Lara; Elma Tchilian; Sonja Firner; Daniel Engeler; Burkhard Ludewig; Paul Klenerman
Journal:  J Immunol       Date:  2013-03-18       Impact factor: 5.422

10.  CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccination.

Authors:  Channakeshava Sokke Umeshappa; Roopa Hebbandi Nanjundappa; Yufeng Xie; Andrew Freywald; Yulin Deng; Hong Ma; Jim Xiang
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.